Reoperation for isolated rheumatic tricuspid regurgitation.
Moutakiallah Y, Aithoussa M, Atmani N, Seghrouchni A, Moujahid A, Hatim A, Asfalou I, Lakhal Z, Boulahya A.
J Cardiothorac Surg. 2018 Oct 4;13(1):104. doi: 10.1186/s13019-018-0793-7.
PMID:30286778
Prevalence and predictors of non-rheumatic valvular heart disease in patients with sickle cell disease: insights from the National In-Patient Database in 2016 and 2017.
Prevalence of Coronary Artery Disease in Patients Undergoing Valvular Heart Surgery.
Ren C, Yu J, Zhang J, Wang S, Zhu E, Guo H, Sun D, Tang B, Cui H, Lai Y.
Heart Surg Forum. 2023 Mar 3;26(2):E141-E147. doi: 10.1532/hsf.5331.
PMID:36972598
Evolution of repaired and non-repaired tricuspid regurgitation in rheumatic mitral valve surgery without severe pulmonary hypertension.
Kirali K, Omeroğlu SN, Uzun K, Erentuğ V, Bozbuğa N, Eren E, Balkanay M, Alp M, Yakut C.
Asian Cardiovasc Thorac Ann. 2004 Sep;12(3):239-45. doi: 10.1177/021849230401200313.
PMID:15353464
Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes.
Kim JB, Yoo DG, Kim GS, Song H, Jung SH, Choo SJ, Chung CH, Lee JW.